$ARDT

Securities class action filed against Ardent Health after November 2025 disclosure of $43M revenue decrease and undisclosed liability reserves. Stock fell 34%; lead plaintiff applications due March 9, 2026.

Ardent Health faces class action lawsuit for overstating Q3 2025 revenue and EBITDA guidance by $57.5 million due to inadequate accounting assessments and cost pressures.

Ardent Health faces class action lawsuit over inflated receivables and delayed loss recognition. Stock dropped 34% after $43M revenue restatement; investors have until March 9 to join.

Pomerantz LLP sues Ardent Health for securities fraud over November 2025 disclosures revealing $43M revenue decrease and $57.5M EBITDA cut, causing 33.81% stock decline. Shareholders can join by March 9.

Pomerantz files class action lawsuit against Bath & Body Works for alleged securities violations following missed earnings and stock decline in 2025.

Ardent Health Services faces securities lawsuit alleging $97M reserve accounting misstatements. Company used simplified methodology contradicting prior disclosures, triggering 33% stock decline.

Rosen Law Firm sues Enphase Energy for allegedly misrepresenting inventory management and overstating financial outlook regarding tax credit impacts.

Ardent Health investors must join securities class action by March 9, 2026, alleging company misrepresented financial reporting and insurance coverage practices.

Ardent Health shares plunged 33% after revealing a $43 million revenue adjustment due to overstated receivables. A securities fraud lawsuit was filed over misleading accounting disclosures.

Securities lawsuit filed against Ardent Health for alleged accounting misrepresentations. Lead plaintiff deadline set for March 9, 2026.

Ardent Health faces securities lawsuit over undisclosed financial declines. Lead plaintiff applications due March 9, 2026 for investors with losses exceeding $100,000.

Schall Law Firm sues Ardent Health for securities fraud, alleging material misrepresentations about accounts receivable practices and insurance coverage between July 2024 and November 2025.

Ardent Health faces securities class action for allegedly inflating receivables through misleading accounting practices. Class period runs July 2024 through November 2025.

Law firm Hagens Berman investigates Ardent Health for securities fraud over $97M accounting adjustments. Stock fell 33% after November disclosure of revenue revisions and reserve increases.

Ardent Health faces securities lawsuit alleging accounting fraud to overstate revenue through manipulated accounts receivable and delayed uncollectible recognition during 2024-2025.

Class action lawsuit filed against Ardent Health for allegedly overstating Q3 2025 revenue and inflating full-year EBITDA guidance by $57.5 million due to accounting system failures.

Law firm investigates Ardent Health for allegedly false financial disclosures. Stock fell 33.81% after company revealed $43M revenue cut, $54M liability increase. Investors have until March 9 to join class action.

Ardent Health faces class action lawsuit over misrepresented revenue recognition practices. Company disclosed $43M revenue reduction and 33% stock decline following accounting restatement allegations.

Class action lawsuit filed against Ardent Health for allegedly misrepresenting accounting practices and collection methodologies to investors between July 2024 and November 2025.